The effect of depressive symptoms and CD4 count on adherence to highly active antiretroviral therapy in sub-saharan africa

Journal of the International Association of Providers of AIDS Care

Volumn 13, Issue 4, 2014, Pages 346-352

  Memiah, Peter ^a   Shumba, Constance ^b   Etienne Mesubi, Martine ^a   Agbor, Solomon ^a   Hossain, Mian B ^a,c   Komba, Patience ^b   Niyang, Mercy ^b   Biadgilign, Sibhatu ^d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF HUMAN VIROLOGY   (United States)

^c Morgan State College   (United States)

^d JIMMA UNIVERSITY   (Ethiopia)

Author keywords

Adherence; CD4; Depressive symptoms; HAART

Indexed keywords

EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; STAVUDINE; ZIDOVUDINE; ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; AGING; ARTICLE; BECK DEPRESSION INVENTORY; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE COURSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MENTAL HEALTH; MULTICENTER STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT COMPLIANCE; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; TREATMENT DURATION; CLINICAL TRIAL; HIV INFECTIONS; IMMUNOLOGY; MEDICATION COMPLIANCE; MIDDLE AGED; PSYCHOLOGY; RETROSPECTIVE STUDY; VIROLOGY; YOUNG ADULT; COMPLICATION; STATISTICS AND NUMERICAL DATA; CLINICAL EVALUATION; DEPENDENT VARIABLE; DISEASE ASSOCIATION; EXPLANATORY VARIABLE; HEALTH SURVEY; HUMAN IMMUNODEFICIENCY VIRUS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY (TOPIC); OBSERVATIONAL STUDY; OPPORTUNISTIC INFECTION; POPULATION;

ADOLESCENT; AFRICA SOUTH OF THE SAHARA; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT; ADULT; ANTI-RETROVIRAL AGENTS; DEPRESSION;

EID: 84905740501     PISSN: 23259574     EISSN: 23259582     Source Type: Journal    
DOI: 10.1177/2325957413503368     Document Type: Article

References (47)

1. Bangsberg D, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(91181-1183.
2. Golin C, Liu H, Hays RD, et al. A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med. 2002;17(10756-765.
3. Paterson D, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(121-30.
4. Collins P, Holmand AR, Freemane MC, Patel V. What is the relevance of mental health to HIV/AIDS care and treatment programs in developing countries? A systematic review. AIDS. 2006; 20(121571-1582.
5. Kinyanda E, Hoskins S, Nakku J, Nawaz S, Patel V. Prevalence and risk factors of major depressive disorder in HIV/AIDS as seen in semi-urban Entebbe district, Uganda. BMC Psychiatry. 2011; 11:205.
6. Burack J, Barrett DC, Stall RD, Chesney MA, Ekstrand ML Coates TJ. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA. 1993;270(212568-2573.
7. Cook JA, Grey D, Burke J, et al. Depressive symptoms and AIDSrelated mortality among a multisite cohort of HIV-positive women. Am J Public Health. 2004;94(71133-1140.
8. Lyketsos CG, Hoover DR, Guccione M, et al. Depressive symptoms over the course of HIV infection before AIDS. Soc Psychiatry Psychiatr Epidemiol. 1996;31(3-4212-219.
9. Williams P, Narciso L, Browne G, Roberts J, Weir R, Gafni A. The prevalence, correlates, and costs of depression in people living with HIV/AIDS in Ontario: implications for service directions. AIDS Educ Prev. 2005;17(2119-130.
10. Gordillo V, del Amo J, Soriano V, González-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999;13(131763-1769.
11. Bing E, Burnam MA, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58(8 721-728.
12. Wagner GJ, Holloway I, Ghosh-Dastidar B, Kityo C, Mugyenyi P. Understanding the influence of depression on self-efficacy, work status and condom use among HIV clients in Uganda. J Psychosom Res. 2011;70(5440-448.
13. Wu D, Munoz M, Espiritu B, et al. Depression among impoverished HIV-positive women. J Acquir Immune deficiency Syndr. 2008;48(4500-504.
14. Nakimuli-Mpungu E, MS Katabira E, Nachega J, Bass J. Prevalence and factors associated with depressive disorders in an HIV+ rural patient population in southern Uganda. J Affect Disord. 2011;135(1-3160-167.
15. Penzak S, Reddy YS, Grimsley SR. Depression in patients with HIV infection. Am J Health Syst Pharm. 2000;57(4 376-386.
16. Haubrich R, Little SJ, Currier JS, et al. The value of patientreported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS. 1999;13(91099-1107.
17. Holzemer W, Corless IB, Nokes KM, Turner JG. Predictors of self-reported adherence in persons living with HIV disease. AIDS Patients Care STDs. 1999;13(3185-197.
18. Turner B, Laine C, Cosler L. Relationship of gender, depression and health care delivery with antiretroviral adherence in HIVinfected drug users. J Gen Intern Med. 2003;18(4248-257.
19. Martin L, Williams SL, Haskard KB, DiMatteo MR. The challenge of patient adherence. Ther Clin Risk Manag. 2005;1(3 189-199.
20. Low-Beer S, Yip B, O'Shaughnessy MV, Hogg RS, Montaner JS. Adherence to triple therapy and viral load response. J Acquir Immune Defic Syndr. 2000;23(4360-361.
21. Reiter G, Wojtusik L, Hewitt R, et al. Elements of success in HIV clinical care. Top HIV Med. 2000;8: article 67.
22. Ickovics JR, Meade CS. Adherence to antiretroviral therapy among patients with HIV: a critical link between behavioural and biomedical sciences. J Acquir Immune Defic Syndr. 2002; 31(suppl 3S98-S102.
23. Amberbir A, Woldemichael K, Getachew S, Girma B, Deribe K. Predictors of adherence to antiretroviral therapy among HIVinfected persons: a prospective study in Southwest Ethiopia. BMC Public Health. 2008;30:265.
24. Dimatteo M, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(142101-2107.
25. Carrieri M, Amass L, Lucas GM, Vlahov D, Wodak A, Woody GE. Buprenorphine use: the international experience. Clin Infect Dis. 2006;43(suppl 4S197-S215.
26. Etienne M, Hossain M, Redfield R, Stafford K, Amoroso A. Indicators of adherence to antiretroviral therapy treatment among HIV/AIDS patients in 5 African countries. J Int Assoc Physicians AIDS Care(Chic). 2010;9(298-103.
27. Ownby R JR, Waldrop-Valverde D, Gould F. Depression care and prevalence in HIV-positive individuals. Neurobehavioural HIV Med. 2010;1:73-83.
28. StataCorp [computer program]. Stata Statistical Software: Release 9. College Station, TX: StataCorp LP; 2005.
29. Mills E, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296(6679-690.
30. Abaasa A, Todd J, Ekoru K, et al. Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda. BMC Health Serv Res. 2008;8:241.
31. Reda AA, Biadgilign S. Determinants of adherence to antiretroviral therapy among HIV-infected patients in Africa. AIDS Res Treat. 2012;2012:574656.
32. Myer L, Smit J, Roux LL, Parker S, Stein DJ, Seedat S. Common mental disorders among HIV-infected individuals in South Africa: prevalence, predictors, and validation of brief psychiatric rating scales. AIDS Patient Care STDs. 2008;22(2147-158.
33. Brandt R. The mental health of people living with HIV/AIDS in Africa: a systematic review. Afr J AIDS Res. 2009;8(2123-133.
34. Starace F, Ammassari A, Trotta MP, et al. AdICoNA Study Group. NeuroICoNA Study Group. Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31(suppl 3S136-S139.
35. Grenard JL Munjas BA, Adams JL, et al. Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis. J Gen Intern Med. 2011;26(101175-1182.
36. Ramadhani HO, Thielman N, Landman KZ, et al. Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania. Clin Infect Dis. 2007;45(111492-1498.
37. Antelman G, Kaaya S,Wei R, et al. Depressive symptoms increase risk of HIV disease progression and mortality among women in Tanzania. J Acquir Immune Defic Syndr. 2007;44(4470-477.
38. Jia H, Uphold CR, Wu S, Reid K, Findley K, Duncan PW. Healthrelated quality of life among men with HIV infection: effects of social support, coping, and depression. AIDS Patient Care STDS. 2004;18(10594-603.
39. Metsch L, Bell C, Pereyra M, et al. Hospitalized HIV-infected patients in the era of highly active antiretroviral therapy. Am J Public Health. 2009;99(61045-1049.
40. Saag M. The impact of highly active antiretroviral therapy on HIV-specific immune function. AIDS. 2001;15(suppl 2S4-S10.
41. Raboud JM, Harris M, Rae S, Montaner JS. Impact of adherence on duration of virological suppression among patients receiving combination antiretroviral therapy. HIV Med. 2002; 3(2118-124.
42. Wagner G, Goggin K, Remien RH, et al. A closer look at depression and its relationship to HIV antiretroviral adherence. Ann Behav Med. 2011;42(3352-360.
43. Talam NC, Gatongi P, Rotich J, Kimaiyo S. Factors affecting antiretroviral drug adherence among HIV/AIDS adult patients attending HIV/AIDS clinic at Moi Teaching and Referral Hospital, Eldoret, Kenya. East Afr J Public Health. 2008;5(274-78.
44. Besch C. Compliance in clinical trials. AIDS. 1995;9(11-10.
45. Govender RD, Schlebusch L. Suicidal ideation in seropositive patients seen at a South African HIV voluntary counselling and testing clinic. Afr J Psychiatry (Johannesbg). 2012;15(294-98.
46. Ogunrin OA, Obiabo YO. Depressive symptoms in patients with epilepsy: analysis of self-rating and physician's assessment. Neurol India. 2010;58(4565-570.
47. Davhana-Maselesele M, Igumbor JO. The impact of caring for persons living with HIV and AIDS on the mental health of nurses in the Limpopo Province. Curationis. 2008;31(267-73.